Article History
Received: 4 April 2023
Revised: 16 May 2023
Accepted: 15 June 2023
First Online: 23 June 2023
Declarations
:
: All procedures were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical standards. Ethics approval was obtained from the medical ethics committee of the Federation France Macula.
: The authors declare no competing interests related to the topic. Financial disclosures not related to the topic: SNB: Consulting fees from Abbvie, Bayer, Novartis, and Roche. LD: None. SYC: Consulting fees from Abbvie, Bayer, Novartis, Roche, and Thea.